|
IT1288123B1
(it)
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
|
IT1303671B1
(it)
*
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
|
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
IT1311924B1
(it)
*
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
AP2002002582A0
(en)
|
1999-12-23 |
2002-09-30 |
Nitromed Inc |
Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
IT1319202B1
(it)
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per le malattie a base infiammatoria.
|
|
IT1319201B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per il diabete.
|
|
DE60122939T2
(de)
|
2000-12-21 |
2007-01-11 |
Nitromed, Inc., Bedford |
Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
|
|
AU2002217464B2
(en)
|
2000-12-25 |
2004-12-16 |
Daiichi Sankyo Company, Limited |
Medicinal compositions containing aspirin
|
|
EP1219306A1
(en)
*
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
WO2002087508A2
(en)
|
2001-05-02 |
2002-11-07 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
SE0101702D0
(sv)
|
2001-05-15 |
2001-05-15 |
Ardenia Investments Ltd |
Novel potentiating compounds
|
|
ITMI20010985A1
(it)
*
|
2001-05-15 |
2002-11-15 |
Nicox Sa |
Farmaci per il morbo di alzheimer
|
|
DE10125883A1
(de)
|
2001-05-28 |
2002-12-12 |
Serumwerk Bernburg Ag |
Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
|
|
ITMI20011240A1
(it)
*
|
2001-06-13 |
2002-12-13 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
ITMI20011307A1
(it)
*
|
2001-06-21 |
2002-12-21 |
Nicox Sa |
Farmaci per l'epilessia
|
|
ITMI20011744A1
(it)
*
|
2001-08-09 |
2003-02-09 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
NZ534912A
(en)
|
2002-02-04 |
2007-08-31 |
Alfama Investigacao E Desenvol |
supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
|
|
AU2003223491A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Nitromed, Inc. |
Nitric oxide donors, compositions and methods of use
|
|
AU2003231255A1
(en)
*
|
2002-05-02 |
2003-12-31 |
Osteoscreen, Inc. |
Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate)
|
|
CA2487414A1
(en)
|
2002-06-11 |
2003-12-18 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
|
ITMI20021399A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Inibitori della cicloossigenasi 2
|
|
ITMI20021391A1
(it)
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Nitroderivati di inibitori della cicloossigenasi-2
|
|
JP2005535642A
(ja)
|
2002-06-28 |
2005-11-24 |
ニトロメッド インコーポレーティッド |
オキシムおよび／またはヒドラゾンを含有するニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
|
|
AU2003247792B2
(en)
|
2002-07-03 |
2009-09-24 |
Nicox S.A. |
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
US7244753B2
(en)
|
2002-07-29 |
2007-07-17 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
EP1534278A4
(en)
|
2002-08-01 |
2006-09-06 |
Nitromed Inc |
NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
|
|
ITMI20021861A1
(it)
*
|
2002-08-29 |
2004-02-29 |
Nicox Sa |
Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
AU2004246821A1
(en)
|
2003-06-19 |
2004-12-23 |
Nicox S.A. |
Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
|
|
PL379420A1
(pl)
*
|
2003-07-31 |
2006-09-04 |
Nicox S.A. |
Pochodne blokerów receptora angiotensyny II
|
|
HRP20070283T3
(en)
*
|
2003-12-02 |
2007-11-30 |
Nicox S.A. |
Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
|
|
US20090131342A1
(en)
*
|
2004-01-22 |
2009-05-21 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
|
US7067659B2
(en)
*
|
2004-04-23 |
2006-06-27 |
Duke University |
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
KR20070053214A
(ko)
|
2004-08-26 |
2007-05-23 |
니콜라스 피라말 인디아 리미티드 |
신규 생분해성 링커를 함유하는 프로드럭
|
|
US9579298B2
(en)
|
2004-12-02 |
2017-02-28 |
Piotr Chomczynski |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
US20070122509A1
(en)
*
|
2004-12-02 |
2007-05-31 |
Molecular Research Center, Inc. |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
EP1836160A1
(en)
*
|
2004-12-24 |
2007-09-26 |
CTG Pharma S.r.l. |
Compounds for treating metabolic syndrome
|
|
EP1915157A4
(en)
*
|
2005-08-02 |
2010-09-01 |
Nicox Sa |
NICKEL OXYGENIZING ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND USE PROCESSES
|
|
BRPI0712600B1
(pt)
|
2006-05-19 |
2015-10-27 |
Mary Kay Inc |
composição tópica para cuidados com a pele e método para a esfoliação da pele.
|
|
PT2057139E
(pt)
*
|
2006-07-18 |
2013-12-05 |
Antibe Holdings Inc |
Derivados de sulfureto de hidrogénio de fármacos antiinflamatórios não esteroidais
|
|
CN101501018B
(zh)
*
|
2006-07-18 |
2014-08-27 |
安泰碧控股公司 |
非甾体抗炎药的硫化氢衍生物
|
|
TW200831079A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
CA2724023C
(en)
*
|
2008-05-13 |
2014-02-18 |
Genmedica Therapeutics Sl |
Salicylate conjugates useful for treating metabolic disorders
|
|
MD4009C2
(ro)
*
|
2008-07-15 |
2010-08-31 |
Институт Химии Академии Наук Молдовы |
Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
|
|
CA2775370A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Nitrogenix Inc. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
US9085508B2
(en)
|
2008-09-24 |
2015-07-21 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
US7807716B2
(en)
*
|
2008-09-24 |
2010-10-05 |
Oral Delivery Technology Ltd. |
Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
|
|
EP2194048A1
(en)
*
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
US20100239552A1
(en)
*
|
2009-03-16 |
2010-09-23 |
Genmedica Therapeutics Sl |
Combination Therapies for Treating Metabolic Disorders
|
|
JP2012520342A
(ja)
*
|
2009-03-16 |
2012-09-06 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
|
|
WO2011032936A1
(en)
*
|
2009-09-15 |
2011-03-24 |
Dsm Ip Assets B.V. |
Nitrooxyesters, their preparation and use
|
|
WO2011056561A1
(en)
|
2009-10-27 |
2011-05-12 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2011057386A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Oral Delivery Technology Ltd. |
Composition and prophylactic device for enhancing sexual performance or pleasure
|
|
IT1397212B1
(it)
*
|
2009-12-29 |
2013-01-04 |
Flamma Spa |
Derivati di amminoalcoli e loro attivita' terapeutica
|
|
AR081268A1
(es)
|
2010-06-02 |
2012-07-18 |
Cardiolynx Ag |
Derivados de nitrato de pioglitazona
|
|
CN102442908A
(zh)
*
|
2010-10-14 |
2012-05-09 |
天津药物研究院 |
制备萘普西诺的中间体及方法
|
|
GB201020811D0
(en)
*
|
2010-12-08 |
2011-01-19 |
Solvotrin Innovations Ltd |
Compounds
|
|
US8466197B2
(en)
|
2010-12-14 |
2013-06-18 |
Genmedica Therapeutics Sl |
Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
|
|
EP2699242B1
(en)
|
2011-04-19 |
2017-11-01 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
US10487114B2
(en)
|
2011-04-27 |
2019-11-26 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
|
|
JP6134710B2
(ja)
|
2011-07-21 |
2017-05-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化ルテニウム放出分子およびその使用
|
|
EP2967045B1
(en)
|
2013-03-12 |
2019-06-26 |
Mary Kay, Inc. |
Preservative system
|
|
CA3042642A1
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
WO2015086838A2
(en)
*
|
2013-12-13 |
2015-06-18 |
Conaris Research Institute Ag |
A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
KR20160102210A
(ko)
|
2013-12-27 |
2016-08-29 |
노버스 인터내쇼날 인코포레이티드 |
에톡시화 계면활성제
|
|
CA2955229C
(en)
|
2014-07-17 |
2020-03-10 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
ES2632808T3
(es)
|
2014-09-04 |
2017-09-15 |
Nicox Science Ireland |
Compuestos de carnosina donadores de óxido nítrico
|
|
AU2015336065A1
(en)
|
2014-10-20 |
2017-05-04 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
CN104478727A
(zh)
*
|
2014-12-22 |
2015-04-01 |
江西本草天工科技有限责任公司 |
一种阿魏酸释放一氧化氮的衍生物及其用途
|
|
CN105061286B
(zh)
*
|
2015-09-08 |
2017-11-24 |
上海蓝木化工有限公司 |
一种炔基取代吡咯类化合物的合成方法
|
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
|
PL3588666T3
(pl)
|
2017-08-14 |
2022-10-10 |
Lg Energy Solution, Ltd. |
Pakiet akumulatorowy o ulepszonych parametrach kontroli temperatury
|
|
US11564970B2
(en)
*
|
2017-10-09 |
2023-01-31 |
The Broad Institute, Inc. |
Compositions and methods for combinatorial drug discovery in nanoliter droplets
|
|
CN109942455A
(zh)
*
|
2019-03-10 |
2019-06-28 |
陕西科技大学 |
具有抗肿瘤活性的棉酚-依氟鸟氨酸席夫碱化合物及其合成方法
|
|
CN111087302B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬阿魏酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
CN111087301B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬咖啡酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
WO2022138842A1
(ja)
*
|
2020-12-24 |
2022-06-30 |
参天製薬株式会社 |
エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
|
|
CN115500355B
(zh)
*
|
2022-09-09 |
2024-02-09 |
广东省农业科学院果树研究所 |
利用Podophyllotoxin和Gentisic acid防治荔枝霜疫霉病
|
|
US12564326B2
(en)
|
2022-10-25 |
2026-03-03 |
GE Precision Healthcare LLC |
Non-invasive bilirubin detection using induced photoreaction
|
|
CN116375698B
(zh)
*
|
2023-06-05 |
2023-08-01 |
中国林业科学研究院林产化学工业研究所 |
具有靶向抗肿瘤活性的漆酚基异羟肟酸型hdac抑制剂及其制备方法和应用
|